AA
WST icon

Ancora Advisors’s West Pharmaceutical WST Stock Holding History

Ancora Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-71
Closed -$17.8K – 2399
2026
Q1 		$17.8K Buy
71
+6
+9% +$1.49K ﹤0.01% 1579
2025
Q4 		$17.9K Buy
65
+64
+6,400% +$17.5K ﹤0.01% 1599
2025
Q3 		$262 Hold
1
– – ﹤0.01% 1883
2025
Q2 		$219 Buy
+1
New +$214 ﹤0.01% 1892
2025
Q1 		– Sell
-1
Closed -$328 – 1899
2024
Q4 		$328 Buy
+1
New +$315 ﹤0.01% 1703
2024
Q2 		– Sell
-3
Closed -$1.17K – 1925
2024
Q1 		$1.17K Hold
3
– – ﹤0.01% 1612
2023
Q4 		$1.04K Hold
3
– – ﹤0.01% 1542
2023
Q3 		$1.11K Hold
3
– – ﹤0.01% 1555
2023
Q2 		$1.13K Buy
+3
New +$1.07K ﹤0.01% 1552

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ancora Advisors's WST Position: Q2 2026 in Review

Ancora Advisors sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 71 shares — an estimated $17.8K sold.

Ancora Advisors first reported a position in WST in Q2 2023 and held it in 9 quarters. The position peaked at $17.9K in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Ancora Advisors reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Ancora Advisors sold 71 West Pharmaceutical shares in Q2 2026, an estimated $17.8K.
  • Ancora Advisors first reported a position in West Pharmaceutical in Q2 2023 and held it in 9 quarters.
  • Ancora Advisors's West Pharmaceutical position peaked at $17.9K in Q4 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.